116 related articles for article (PubMed ID: 10604823)
1. Sensitive methods for determination of free digitoxin concentration using digitoxin immunoassays: demonstration of elevated free digitoxin concentration caused by digitoxin-phenytoin interaction by applying these new techniques.
Dasgupta A; Vega AE; Wells A; Datta P
Ther Drug Monit; 1999 Dec; 21(6):625-30. PubMed ID: 10604823
[TBL] [Abstract][Full Text] [Related]
2. Interference of oleandrin and oleandrigenin in digitoxin immunoassays: minimal cross reactivity with a new monoclonal chemiluminescent assay and high cross reactivity with the fluorescence polarization assay.
Datta P; Dasgupta A
Ther Drug Monit; 1997 Aug; 19(4):465-9. PubMed ID: 9263390
[TBL] [Abstract][Full Text] [Related]
3. Effect of digoxin fab antibody on the measurement of total and free digitoxin by fluorescence polarization and a new chemiluminescent immunoassay.
Dasgupta A; Wells A; Datta P
Ther Drug Monit; 1999 Apr; 21(2):251-5. PubMed ID: 10217348
[TBL] [Abstract][Full Text] [Related]
4. Uremic sera contain inhibitors that block digitoxin-valproic acid interaction.
Dasgupta A; Paul A; Wells A
Am J Med Sci; 2001 Oct; 322(4):204-8. PubMed ID: 11678517
[TBL] [Abstract][Full Text] [Related]
5. Rapid detection of cardioactive bufalin toxicity using fluorescence polarization immunoassay for digitoxin.
Dasgupta A; Datta P
Ther Drug Monit; 1998 Feb; 20(1):104-8. PubMed ID: 9485564
[TBL] [Abstract][Full Text] [Related]
6. Falsely elevated serum digitoxin concentrations due to cross-reactivity of water-extractable digitoxin-like immunoreactivity of Chinese medicine Chan SU: elimination of interference by use of a chemiluminescent assay.
Biddle DA; Datta P; Wells A; Dasgupta A
Clin Chim Acta; 2000 Oct; 300(1-2):151-8. PubMed ID: 10958871
[TBL] [Abstract][Full Text] [Related]
7. Interactions between drugs and Asian medicine: displacement of digitoxin from protein binding site by bufalin, the constituent of Chinese medicines Chan Su and Lu-Shen-Wan.
Datta P; Dasgupta A
Ther Drug Monit; 2000 Apr; 22(2):155-9. PubMed ID: 10774625
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional (positive/negative) interference in a digoxin immunoassay: importance of antibody specificity.
Datta P; Dasgupta A
Ther Drug Monit; 1998 Jun; 20(3):352-7. PubMed ID: 9631936
[TBL] [Abstract][Full Text] [Related]
9. Protein binding of digitoxin, valproate and phenytoin in sera from diabetics.
Doucet J; Fresel J; Hue G; Moore N
Eur J Clin Pharmacol; 1993; 45(6):577-9. PubMed ID: 8157046
[TBL] [Abstract][Full Text] [Related]
10. Unexpected suppression of total digoxin concentrations by cross-reactants in the microparticle enzyme immunoassay: elimination of interference by monitoring free digoxin concentration.
Dasgupta A; Scott J
Am J Clin Pathol; 1998 Jul; 110(1):78-82. PubMed ID: 9661925
[TBL] [Abstract][Full Text] [Related]
11. Use of alkaline phosphatase to correct the underestimation of fosphenytoin concentration in serum measured by phenytoin immunoassays.
Dasgupta A; Warner BF; Datta P
Am J Clin Pathol; 1999 Apr; 111(4):557-62. PubMed ID: 10191778
[TBL] [Abstract][Full Text] [Related]
12. Interference from digitoxin-like immunoreactive factors reduced in a new monoclonal chemiluminescent digitoxin assay.
Datta P; Dasgupta A
Ther Drug Monit; 1998 Dec; 20(6):663-8. PubMed ID: 9853984
[TBL] [Abstract][Full Text] [Related]
13. Mathematical models to calculate fosphenytoin concentrations in the presence of phenytoin using phenytoin immunoassays and alkaline phosphatase.
Dasgupta A; Handy BC; Datta P
Am J Clin Pathol; 2000 Jan; 113(1):87-92. PubMed ID: 10631861
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of cardiac toxins oleandrin, oleandrigenin, bufalin, and cinobufotalin by digibind: monitoring the effect by measuring free digitoxin concentrations.
Dasgupta A; Emerson L
Life Sci; 1998; 63(9):781-8. PubMed ID: 9740315
[TBL] [Abstract][Full Text] [Related]
15. Unexpected suppression of free phenytoin concentration by salicylate in uremic sera due to the presence of inhibitors: MALDI mass spectrometric determination of molecular weight range of inhibitors.
Biddle DA; Wells A; Dasgupta A
Life Sci; 2000; 66(2):143-51. PubMed ID: 10666010
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of oleander poisoning using fluorescence polarization immunoassay for digitoxin. Effect of treatment with digoxin-specific Fab antibody fragment (ovine).
Dasgupta A; Hart AP
Am J Clin Pathol; 1997 Oct; 108(4):411-6. PubMed ID: 9322594
[TBL] [Abstract][Full Text] [Related]
17. Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus.
Dasgupta A; McLemore JL
Ther Drug Monit; 1998 Feb; 20(1):63-7. PubMed ID: 9485557
[TBL] [Abstract][Full Text] [Related]
18. Effect of plantain on therapeutic drug monitoring of digoxin and thirteen other common drugs.
Dasgupta A; Davis B; Wells A
Ann Clin Biochem; 2006 May; 43(Pt 3):223-5. PubMed ID: 16704760
[TBL] [Abstract][Full Text] [Related]
19. Digitoxinlike and digoxinlike immunoreactivitis in sera of patients with uremia and liver disease as measured by fluorescence polarization immunoassays: poor correlation between digitoxinlike and digoxinlike immunoreactivities.
Luke M; Dasgupta A
Ther Drug Monit; 1997 Apr; 19(2):230-5. PubMed ID: 9108656
[TBL] [Abstract][Full Text] [Related]
20. Studies on digitalis. V. The influence of impaired renal function, hemodialysis, and drug interaction on serum protein binding of digitoxin and digoxin.
Storstein L
Clin Pharmacol Ther; 1976 Jul; 20(1):6-14. PubMed ID: 776491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
